All Resources
Succeed Against Difficult Targets with the Opto™ Plasma B Discovery Workflow on the Beacon® System

Discover how the Opto™ Plasma B Discovery on the Beacon optofluidic system allows Pharma to succeed against difficult targets and deliver best-in-class antibody therapeutics.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Brochure we discuss:

Target to lead molecule in weeks, not months.
Expand your pipeline and maximize revenue.
Access to greater diversity delivers antibodies against the most difficult targets.
Increase the probability of campaign success with the industry’s premier antibody discovery platform.
Get the Brochure